Europese Unie -
Nederlands -
EMA (European Medicines Agency)
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccins - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
tractiva 5 mg tabl.
exeltis germany gmbh - aripiprazol 5 mg - tablet - aripiprazole
België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
tractiva 10 mg tabl.
exeltis germany gmbh - aripiprazol 10 mg - tablet - aripiprazole
België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
tractiva 15 mg tabl.
exeltis germany gmbh - aripiprazol 15 mg - tablet - aripiprazole
België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
tractiva 20 mg tabl.
exeltis germany gmbh - aripiprazol 20 mg - tablet - aripiprazole
België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
tractiva 30 mg tabl.
exeltis germany gmbh - aripiprazol 30 mg - tablet - aripiprazole
Europese Unie -
Nederlands -
EMA (European Medicines Agency)
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenza-virus oppervlakte-antigenen (hemagglutinine en neuraminidase) van stam a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccins - actieve immunisatie tegen het h5n1-subtype van influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
Europese Unie -
Nederlands -
EMA (European Medicines Agency)
zulvac 1+8 ovis
zoetis belgium sa - inactivated bluetongue virus, serotype 1, strain btv-1/alg2006/01, inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02 - bluetongue virus, sheep, inactivated viral vaccines - schapen - actieve immunisatie van schapen van 1. 5 maanden oud om viremie veroorzaakt door bluetonguevirus, serotypen 1 en 8 te voorkomen. begin immuniteit: 21 dagen na voltooiing van het primaire vaccinatieschema. duur van de immuniteit: 12 maanden.